Patient Name: NASREENBEGUM Ref. Doctor: Dr.Abhinav Sample Billing Time: 5/19/2022 10:46:00 AM Patient Id: 0001377422 Lab Id: 05221324035 OP Id: HY-MBV-0522-00059 Sample Collection Date & Time: 19/05/2022 10:53 AM Age/Gender: 28 Years/Female Reporting Date & time: 20/05/2022 11:11 AM CLINICAL BIOCHEMISTRY Investigation Result                          Biological Reference Interval    Specimen:Flouride Plasma Fasting Blood Glucose (Method: Hexokinase) 82  mg/dL 74-106 mg/dL Interpretation : Glucose determination is useful in the diagnosis and treatment of Diabetes mellitus. Elevated levels are found in pancreatitis, pituitary and thyroid dysfunction, renal failure and liver diseases. Low glucose levels are found in insulinoma, hypopituitarism, neoplasms, insulin induced hypoglycemia *** END OF REPORT *** Please correlate clinically                   Test Performed By : Cldoh           Consultant Biochemist Patient Name: NASREENBEGUM Ref. Doctor: Dr.Abhinav Sample Billing Time: 5/19/2022 10:46:00 AM Patient Id: 0001377422 Lab Id: 05221324035 OP Id: HY-MBV-0522-00059 Sample Collection Date & Time: 19/05/2022 10:53 AM Age/Gender: 28 Years/Female Reporting Date & time: 19/05/2022 11:53 AM HAEMATOLOGY COMPLETE BLOOD PICTURE Investigation Result                          Normal Reference Range    Specimen:Blood (K2EDTA) Total Leukocyte Count (Method: Flowcytometry) 7.26  X 10³/uL 4.0-10.0 X 10³/uL Total Red Blood Cell Count (Method: Hydrodynamic Focussing Method) 3.72  X10¹²/L 3.8 - 4.8 X 10¹²/L Hb (Method: SLS - HB) 10.5  g/dL 12.0 - 15.0 g/dL HCT (Method: Calculated) 33.2  % 36 - 46 % Mean Corpuscular Volume (MCV) (Method: RBC Histogram) 89.2  fl 83 - 101 fl Mean Corpuscular Hemoglobin (MCH) (Method: Calculated) 28.2  pg 27 - 32 pg MCHC (Method: Calculated) 31.6  g/dl 31.5 - 34.5 g/dl Platelet Count (Method: Hydrodynamic Focussing Method) 184  X 10³/uL 150 - 410 X 10³/uL DIFFERENTIAL LEUKOCYTE COUNT Neutrophils 76.8  % 2.0-7.5 X 10³/uL (40 - 80%) Lymphocytes 15.0  % 1.0-4.0 X 10³/uL (20 - 40%) Monocytes 6.1  % 0.2-1.0 X 10³/uL(2 - 10%) Eosinophils 1.5  % 0.02-0.5 X 10³/uL (1-6%) Basophils 0.6  % 0.02 - 0.1 X 10³/uL (1-2%) Method Flowcytometry PERIPHERAL SMEAR RBC Normocytic Normochromic   WBC Within Normal Limits   Platelets Adequate   Method Microscopy Notes *** END OF REPORT ***                   Test Performed By : Clpath           Consultant Pathologist Patient Name: NASREENBEGUM Ref. Doctor: Dr.Abhinav Sample Billing Time: 5/19/2022 10:46:00 AM Patient Id: 0001377422 Lab Id: 05221324035 OP Id: HY-MBV-0522-00059 Sample Collection Date & Time: 19/05/2022 10:53 AM Age/Gender: 28 Years/Female Reporting Date & time: 21/05/2022 07:32 AM CLINICAL BIOCHEMISTRY THYROID PROFILE Investigation Result                          Biological Reference Interval    Specimen:Serum T3 - Total (Method: CLIA) 1.03  ng/mL 0.60-1.81 ng/mL T4 -Total (Method: CLIA) 10.3  µg/dL 4.5-10.9 µg/dL Thyroid stimulating hormone (TSH) (Method: CLIA) 1.14  µIU/mL 0.35 – 5.5 µIU/mL Pregnancy: 1st trimester: 0.32 - 4.5 µIU/mL 2nd trimester: 0.52 - 4.6 µIU/mL 3rd trimester: 0.82 - 5.2 µIU/mL Interpretation : TSH alone can only be used to assess thyroid status when the pituitary-thyroid axis is stable. Non-thyroidal illness (NTI), pituitary disease and various drugs can all affect the axis and cause discrepancies between TSH levels, thyroid hormone levels and the clinical state. *** END OF REPORT *** Please correlate clinically                   Test Performed By : cljyothi           Consultant Biochemist Patient Name: NASREENBEGUM Ref. Doctor: Dr.Abhinav Sample Billing Time: 5/19/2022 10:46:00 AM Patient Id: 0001377422 Lab Id: 05221324035 OP Id: HY-MBV-0522-00059 Sample Collection Date & Time: 19/05/2022 10:53 AM Age/Gender: 28 Years/Female Reporting Date & time: 20/05/2022 12:05 PM CLINICAL BIOCHEMISTRY LIVER FUNCTION TEST Investigation Result                          Biological Reference Interval    Specimen:Serum S. Bilirubin T (Method: DPD) 0.38  mg/dL 0.3 - 1.2 mg/dL S.Total Protein (Method: Biuret) 6.02  gm/dL 6.6 - 8.3 gm/dL S.Albumin (Method: BCG) 3.28  gm/dL 3.5 - 5.2 gm/dL Globulin (Method: Calculated) 2.74  gm/dL 2.6-3.9 gm/dL A/G Ratio (Method: Calculated) 1.2   1.0 - 1.7 SGOT/AST (Method: UV without P5P) 19  U/L < 35 U/L SGPT /ALT (Method: UV without P5P) 7  U/L < 35 U/L S.Alkaline Phosphatase (Method: IFCC) 68  U/L 30 - 120 U/L Interpretation : Liver function tests (LFTs or LFs) are groups of blood tests that give information about the state of a patient's liver. Liver transaminases (AST or SGOT and ALT or SGPT) are useful biomarkers of liver injury in a patient with some degree of intact liver function. Some tests are associated with functionality (e.g., albumin), some with cellular integrity (e.g., transaminase), and some with conditions linked to the biliary tract (gamma-glutamyl transferase and alkaline phosphatase). GGT plays a role in the detection of alcoholism, alcoholic liver damage and in monitoring alcohol abstinence. *** END OF REPORT *** Please correlate clinically                   Test Performed By : cljyothi           Consultant Biochemist Patient Name: NASREENBEGUM Ref. Doctor: Dr.Abhinav Sample Billing Time: 5/19/2022 10:46:00 AM Patient Id: 0001377422 Lab Id: 05221324035 OP Id: HY-MBV-0522-00059 Sample Collection Date & Time: 19/05/2022 10:53 AM Age/Gender: 28 Years/Female Reporting Date & time: 19/05/2022 11:53 AM CLINICAL BIOCHEMISTRY RENAL FUNCTION TEST Investigation Result                          Biological Reference Interval    Specimen:Serum Blood Urea (Method: Urease) 10  mg/dL 17 - 43 mg/dL S.Creatinine (Method: Enzymatic) 0.5  mg/dL 0.55 - 1.02 mg/dL S.Uric Acid (Method: Uricase) 3.7  mg/dL 2.6 - 6.0 mg/dL Interpretation *** END OF REPORT *** Please correlate clinically                   Test Performed By : Clpath           Consultant Biochemist Patient Name: NASREENBEGUM Ref. Doctor: Dr.Abhinav Sample Billing Time: 5/19/2022 10:46:00 AM Patient Id: 0001377422 Lab Id: 05221324035 OP Id: HY-MBV-0522-00059 Sample Collection Date & Time: 19/05/2022 10:53 AM Age/Gender: 28 Years/Female Reporting Date & time: 20/05/2022 12:00 PM CLINICAL BIOCHEMISTRY LIPID PROFILE Investigation Result                          Biological Reference Interval    Specimen:Serum S.Total Cholesterol (Method: CHOD-POD) 221  mg/dL Desirable Level : <200 mg/dL Borderline : 200 - 239 mg/dL Undesirable : > 240 mg/dL S.Triglycerides (Method: GPO-POD) 185  mg/dL Desirable Level : <150 mg/dL Borderline : 150 - 199 mg/dL High : 200 - 499 mg/dL Very High : >500 mg/dL S.HDL (Method: Enzyme Selective Inhibition) 65  mg/dL Desirable Level : >60 mg/dL Borderline : 40 - 59 mg/dL Undesirable : <40 mg/dL VLDL (Method: Calculated) 37  mg/dL <30 mg/dL S.LDL (Method: Calculated) 119  mg/dL Optimal : <100 mg/dL Near Optimal : 100 - 129 mg/dL Borderline High : 130 - 159 mg/dL High : 160 - 189 mg/dL Very High : >190 mg/dL T.Chol/HDL (Method: Calculated) 3.4   Low Risk: 3.3-4.4 Average Risk: 4.5-7.1 Moderate Risk: 7.2-11.0 LDL/HDL (Method: Calculated) 1.8   Desirable Level: 0.5-3.0 Borderline Risk: 3.0-6.0 High Risk: >6.0 Interpretation : The results of this test can identify certain genetic diseases and can determine approximate risks for cardiovascular disease, certain forms of pancreatitis, and other diseases *** END OF REPORT *** Please correlate clinically                   Test Performed By : cljyothi           Consultant Biochemist Lab Address: Telangana Diagnostics , Central Lab , IPM Campus, Narayanaguda, Hyd - 500029.